BSX Q1 2026 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Globe and Mail, The
Chairman and Chief Executive Officer — Michael Mahoney Executive Vice President and Chief Financial Officer — Jonathan Monson Chief Medical Officer — Ken Stein Vice President, Investor Relations — Lauren Tengler TAKEAWAYS Organic Revenue Growth -- 9.4% for the quarter, matching the guidance range of 8.5%-10%. Adjusted EPS -- $0.80, up 6%, at the high end of guidance ($0.78-$0.80). Adjusted Operating Margin -- 28.8% for the quarter as reported by Monson; full year margin expansion of 50-75 basis points is targeted. Adjusted Gross Margin -- 70.5%, a 100 basis point decline, mainly due to tariffs and inventory charges from the POLARx Cryoablation system discontinuation. Guidance Change -- Organic revenue growth guidance revised to 6.5%-8% for the year and 5%-7% for Q2, with adjusted EPS guidance now $3.34-$3.41 (9%-11% growth). Region Performance -- U.S. organic revenue up 11%; Asia Pacific operational growth at 12% led by Japan and China; Europe, Middle East, and Af
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Boston Scientific forecasts 2026 organic growth of 6.5% to 8% amid revised outlook for EP and WATCHMAN [Seeking Alpha]Seeking Alpha
- Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor HarmGlobeNewswire
- BSX Q3 2025 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Boston Scientific (NYSE:BSX) Surprises With Q1 CY2026 Sales [Yahoo! Finance]Yahoo! Finance
- Boston Scientific (BSX) had its price target lowered by Barclays PLC from $124.00 to $100.00. They now have an "overweight" rating on the stock.MarketBeat
BSX
Earnings
- 4/22/26 - In-Line
BSX
Sec Filings
- 4/22/26 - Form 8-K
- 4/2/26 - Form EFFECT
- 4/1/26 - Form 424B3
- BSX's page on the SEC website